Scientific Advisory Board

Mart Saarma

Professor of biotechnology, Institute of Biotechnology, University of Helsinki

Chair of DANDRITE's Scientific Advisory Board

Mart Saarma and his group investigate structure, biology and therapeutic potantial of neurotrophic factors. He studies GDNF family of neurotrophic factors and also novel neurotrophic factors CDNF and MANF in the development and in neurodegenerative disease.

Yang Dan


Howard Hughes Medical Institute Investigator and Professor of Neurobiology

Her research aims to elucidate (1) what circuits in the mammalian brain control sleep, and (2) mechanisms by which the frontal cortex exerts top-down executive control.

Photo by Georg Kristiansen

Ole Kiehn

Professor at Department of Neuroscience, University of Copenhagen

Ole Kiehn and his research group study the molecular, cellular, and network diversification of locomotor circuitries in mammals with the goal of providing a unified understanding of the functional organization of neuronal circuits that execute movements.

Rüdiger Klein

Professor at Max-Planck-Institute of Neurobiology

Acting chair of DANDRITE's Scientific Advisory Board

At the Department for Molecules, Signaling, and Development, Prof. Rüdiger Klein's group is interested in understanding the principles of cell-cell communication in the developing and mature nervous system. Besides development, they are also interested in understanding how specific neuron populations contribute to certain types of behavior of adult mice. Furthermore, they also study the molecular mechanisms of neurodegeneration and neuroprotection. 

Glenda Halliday

Professor at Faculty of Medicine, University of New South Wales & Neuroscience Research Australia

Professor Glenda Halliday works on identifying and understanding the pathobiology of different stages of neurodegeneration, knowledge necessary for the development of therapies and strategies for the prevention of neurodegenerative syndromes. Her research has highlighted broader pathological involvement in Parkinson's disease and dementia with Lewy bodies, with recent work suggesting that lysosome dysfunction and immunity are involved. Her basic research is highly cited, with core concepts incorporated into current consensus diagnostic criteria for different non-Alzheimer dementias and Parkinson’s disease.

Kathleen Sweadner

Professor at Dept. Neurosurgery, Massachusetts General Hospital

Professor Kathleen Sweadner's field of expertise is the structure, function, and biological roles of Na,K-ATPase isoforms in excitable tissues.

Jan Egebjerg, Ph.D.

Vice president for Neurodegeneration and Biologics, H. Lundbeck A/S

Jan Egebjerg's expertise centers around drug discovery and CNS disease models with focus on neurodegenerative disorders. His field of expertise further includes molecular neurobiology and pharmacology, and structure functional relationships for drug-target interactions.

Matthias Wilmanns

Head of the Hamburg Unit of the European Molecular Biology Laboratory (EMBL)
Research Director of the Center for Structural Systems Biology (CSSB)

Matthias Willmanns' research group investigates a variety of protein-ligand complexes within the context of biological systems, employing a broad range of molecular and structural biology techniques, namely locally available synchrotron radiation facilities and the future Free Electron Laser in Hamburg. Their specific research interests are on: the architecture of the protein interactome in sarcomeric muscle cells, activity regulation in protein kinases, the architecture of the translocon of peroxisomes, structural systems biology in M. tuberculosis.

Moses V. Chao

Professor of Cell Biology, Neuroscience & Physiology and Psychiatry, Skirball Institute of Biomolecular Medicine, New York University School of Medicine

Moses V. Chao's research group is studying the mechanism of action of trophic factors, such as NGF and BDNF, which are responsible for neuronal survival and synaptic plasticity. Since deficits in trophic factors are responsible for neurological disorders such as Alzheimer¹s and Huntington¹s disease, as well as psychiatric disorders (depression, anxiety), the group is currently defining receptor signal transduction pathways that can ameliorate these disorders.

Carl Petersen

Professor at the Brain Mind Institute, Laboratory of Sensory Processing, EPFL-SV-BMI-LSENS, Switzerland